[1]
J. P. Whelan, “A prospective trial of GreenLight PVP (HPS120) versus transurethral resection of the prostate in the treatment of lower urinary tract symptoms in Ontario, Canada”, CUAJ, vol. 7, no. 9-10, pp. 335–41, Oct. 2013.